Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practice.
Jacques Raphael et al. J Natl Cancer Inst 2023 5
Personalizing neoadjuvant immune-checkpoint inhibition in patients with melanoma
MW Lucas et al, Nat Rev Clin Oncol, May 2023
Assessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy.
Charu Aggarwal et al. JAMA Netw Open 2023 5 (5) e2311181
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
K Chamoto et al, Nat Rev Immunology, April 2023
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 04, 2023
- Content source: